YONDELIS® (trabectedin) for the Treatment of Patients with Advanced Soft Tissue Sarcoma

Survival for Soft Tissue Sarcoma Patients Improved at High-volume Centers

Torisel Improves Event-Free Survival in Rhabdomyosarcoma Patients

Radiation Therapy Is Beneficial after Surgery and Chemotherapy in Children with Rhabdomyosarcoma,

Shorter Chemotherapy Intervals Effective in Ewing Sarcoma

Genetic Change Linked with Rhabdomyosarcoma Survival

Carbon Ion Beam Radiation Effective in Spinal Sarcomas

Isolated Limb Perfusion with TNF and Alkeran® Spares Limbs in Soft-Tissue Sarcomas

Patients with Hereditary Retinoblastoma Have Increased Risk of Soft-tissue Sarcomas

Surgery for Osteosarcoma Increases Cure Rates over Chemotherapy Alone

Gemzar® Plus Taxotere® Active in Recurrent Sarcoma

Dose-intensive Epirubicin and Ifosfamide Followed By Surgery is an Effective for the Treatment of Adults with Sarcomas

Children with Sarcoma at Higher Risk for Blood Clots

PET Useful for Initial Evaluation of Children with Rhabdomyosarcoma

PET Scan More Accurate Predictor of Treatment Response for Soft Tissue Sarcomas

Nexavar Improves Survival for Patients with Rare Sarcomas.

Percutaneous Core Needle Biopsy Recommended for Diagnosis of Sarcomas

Evaluation of anlotinib in sarcoma appears promising and confirmatory trials and ongoing in the United States.

Differences in IMRT Radiation Doses May Complicate Study Results in Sarcomas

Taxotere® plus Gemzar® Provides Anticancer Responses in Metastatic Soft-Tissue Sarcomas

Early phases of clinical trials evaluating a new compound called

Addition of Avastin® to Chemotherapy May Slow Disease Progression in Metastatic Soft-Tissue Sarcoma

Paclitaxel Shows Activity against Angiosarcoma of the Scalp and Face

Combination of Irinotecan and Vincristine Active Against Metastatic Rhabdomyosarcoma

Surgery for Recurrent Rhabdomyosarcoma May Improve Survival

Gleevec® Produces a Treatment Response in Some Patients with Desmoid Tumors

New Combination Therapy for Soft-Tissue Sarcoma of the Arm or Leg May Spare Limb

Camptosar® Evaluated in Children with Relapsed or Refractory Rhabdomyosarcoma

Stem Cell Transplantation Improves Survival for Select Patients with Soft-Tissue Sarcoma

Chromosomal Changes Linked with Prognosis in Adult Soft Tissue Sarcoma

Thalidomide Produces Responses in Persons with AIDS-Related Kaposi’s Sarcoma

Researchers Evaluate Treatment Outcomes for Children with Non-Rhabdomyosarcoma Soft-Tissue Sarcomas

Additional Chemotherapy to Standard Regimen Improves Survival in Ewing’s Sarcoma

High-risk Soft Tissue Sarcoma Patients Benefit from Targeted Heat Therapy Combined with Chemotherapy

Targeted Heat Therapy Improves Outcomes for Soft Tissue Sarcoma

Long-Term Follow-Up Care Needed for Osteosarcoma Patients

Determining Risk for Relapse Allows Less Radiation Therapy for Some Children with Soft-Tissue Sarcoma

Molecular Markers Detect Cancer Spread in Rhabdomyosarcoma

Larotrectinib Demonstrates 76 Percent Response Rate in TRK Fusion Cancers Including Sarcomas.

Children with Ewing’s Sarcoma or Astrocytoma Most Likely to Experience Late Recurrence

Sirolimus Effectively Halts Kaposi’s Sarcoma in Renal Transplant Patients

Gleevec® Promising for AIDS-Related Kaposi’s Sarcoma

High-Dose Therapy May Improve Outcome for Patients with Relapsed Ewing’s Sarcoma